STAY INFORMED. VISIT NHIA.ORG/COVID19 FOR INFORMATION AND RESOURCES ABOUT CORONAVIRUS DISEASE (COVID-19).
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022.
The National Home Infusion Association (NHIA) is pleased to announce the 2022 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2022 sponsor of the NHIA Fellow Program.
The National Home Infusion Foundation (NHIF) is proud to announce that Melissa Leone, RN, BSN is the recipient of the 2022 Lynn Giglione Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce that Dr. Sohail Masood, PharmD is the recipient of the 2022 Gene Graves Lifetime Achievement Award.
CMS recently issued a report which summarizes utilization trends for the Medicare Part B home infusion therapy (HIT) services benefit indicating the benefit has failed to draw sufficient participation from providers to ensure equitable access to beneficiaries across the U.S.
Free for all members, NHIA University houses our complete library of educational content for all roles and interests within home and alternate site infusion. The categorized and searchable interface provides a personalized learning dashboard tied to your NHIA member account and includes all of our continuing education (CE) credit offerings for Pharmacists, Pharmacy Technicians, RNs & RDs.
NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.
The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.
Ambulatory infusion pump sets for use in the United States are in limited supply. NHIA has developed product shortage recommendations to help clinicians manage patients during this time when pump sets may not be readily available.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.
Please know that NHIA is here to help in whatever ways we can. If your organization is struggling to source supplies, arrange for alternative patient care, understand how emergency declarations and waivers impact your operations, or anything else, feel free to reach out to us.
With Eitan Medical’s global footprint, this strategic partnership expands the international presence within the advisory group and will inform the discussion around bringing connected technology solutions to the home and alternate site infusion industry.
Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.
This strategic partnership between NHIA and PlayMaker Health will bring a unique perspective to the FIAC, adding support for data-driven programs critical to expanding access of home and alternate site infusion.
Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a
Registration is now open for the National Home Infusion Association’s 2022 Annual Conference, to be held March 12-16, 2022, at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee.
The National Home Infusion Foundation (NHIF) is proud to announce that the recipient of the 2022 Outstanding Abstract Achievement Award (OAAA) is Cheyenne D. Johnson, PharmD from Option Care Health.
The National Home Infusion Foundation (NHIF) announces the finalists for its the Outstanding Abstract Achievement Award for 2022.
The National Home Infusion Association (NHIA) is pleased to announce the 2022 Fellow Program (FNHIA) cohort, made up of highly accomplished home and alternate site infusion professionals. The program is administered and funded by the National Home Infusion Foundation (NHIF), thanks to a generous contribution from Integrated Medical Systems, Inc. (IMS), the 2022 sponsor of the NHIA Fellow Program.
The National Home Infusion Foundation (NHIF) is proud to announce that Melissa Leone, RN, BSN is the recipient of the 2022 Lynn Giglione Women in Leadership Award.
The National Home Infusion Association (NHIA) is proud to announce that Dr. Sohail Masood, PharmD is the recipient of the 2022 Gene Graves Lifetime Achievement Award.
CMS recently issued a report which summarizes utilization trends for the Medicare Part B home infusion therapy (HIT) services benefit indicating the benefit has failed to draw sufficient participation from providers to ensure equitable access to beneficiaries across the U.S.
Free for all members, NHIA University houses our complete library of educational content for all roles and interests within home and alternate site infusion. The categorized and searchable interface provides a personalized learning dashboard tied to your NHIA member account and includes all of our continuing education (CE) credit offerings for Pharmacists, Pharmacy Technicians, RNs & RDs.
NHIA has developed product shortage recommendations to help clinicians manage patients during this time when diluents, and small and large volume parenteral solutions may not be readily available.
The groups ask regulators to assess the impact of these businesses on critical drug shortages and for states to regulate them appropriately.
Ambulatory infusion pump sets for use in the United States are in limited supply. NHIA has developed product shortage recommendations to help clinicians manage patients during this time when pump sets may not be readily available.
CMS issued the Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) final rule and is not finalizing its interpretation of the “appropriate for use in the home” requirement in the definition of DME as it applies to certain external infusion pumps.
Please know that NHIA is here to help in whatever ways we can. If your organization is struggling to source supplies, arrange for alternative patient care, understand how emergency declarations and waivers impact your operations, or anything else, feel free to reach out to us.
With Eitan Medical’s global footprint, this strategic partnership expands the international presence within the advisory group and will inform the discussion around bringing connected technology solutions to the home and alternate site infusion industry.
Learn about the new LCDs, what it means for home PEN patients and home providers and the challenges that still exist in home PEN Medicare coverage which will require advocacy from NHIA, ASPEN, home care clinicians and patients.
This strategic partnership between NHIA and PlayMaker Health will bring a unique perspective to the FIAC, adding support for data-driven programs critical to expanding access of home and alternate site infusion.
Advocacy News CMS Issues Multiple Regulations Affecting Home and Alternate Site Infusion November 4, 2021 This week, the Centers for Medicare & Medicaid Services (CMS) released a
Registration is now open for the National Home Infusion Association’s 2022 Annual Conference, to be held March 12-16, 2022, at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee.
